The elimination of pre-funded warrant overhang removes a dilutive overhang but provides no new capital. With only $2M market cap and no revenue catalyst disclosed, watch for the next quarterly report to assess cash runway and any operational update.
Price Chart
Executive Summary
Aethlon Medical filed an 8-K disclosing that all previously outstanding pre-funded warrants have been exercised, leaving 1,604,095 shares of common stock outstanding as of August 28, 2026. This removes future dilutive overhang from those warrants but confirms that all related cash proceeds have already been received by the company.
Key Facts
- All previously outstanding pre-funded warrants have been exercised as of August 28, 2026.
- Aethlon Medical now has 1,604,095 shares of common stock outstanding.
- The company has no remaining pre-funded warrant overhang.
Financial Impact
No financial figures provided beyond share count. The pre-funded warrant exercises already generated cash, but amount is undisclosed.
Risk Factors
- No forward-looking commentary on operations or revenue was provided.
- The tiny market cap ($2M) and thin share count suggest high volatility risk on any news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-006815 |
| Document: 0001683168-26-006815-index-headers.html | 0001683168-26-006815 |
| Document: 0001683168-26-006815-index.html | 0001683168-26-006815 |
| Document: 0001683168-26-006815.txt | 0001683168-26-006815 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | SC 13G | $5.05 $5.07 | ▲ +0.40% | ▼ −0.06% | $5.05 (+0.00%) |
Oct 1, 2026 25d ago | 8-K | $6.45 $6.05 | ▲ +6.20% | ▲ +7.36% | $5.05 (+21.71%) |
Sep 17, 2026 5w ago | 425 | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.05 (−25.52%) |
Sep 17, 2026 5w ago | 8-K | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.05 (−25.52%) |
Sep 15, 2026 5w ago | 8-K | $1.47 $6.31 | ▲ +329.25% | ▲ +328.43% | $5.05 (+243.54%) |
Sep 4, 2026 7w ago | DEFA14A | $1.81 $1.47 | ▲ +18.78% | ▲ +17.67% | $5.05 (−179.01%) |
Aug 31, 2026 8w ago | 8-K | $2.06 $1.81 | ▼ −12.14% | ▼ −11.99% | $5.05 (+145.15%) |
Aug 13, 2026 10w ago | Press Release | $2.83 $2.73 | ▼ −3.53% | ▼ −2.17% | $5.05 (+78.45%) |
Jul 31, 2026 12w ago | 8-K | $0.6628 $0.6300 | ▲ +4.95% | ▲ +8.46% | $5.05 (−661.92%) |
Jul 7, 2026 15w ago | EFFECT | $0.7297 $0.6850 | ▲ +6.13% | ▲ +6.68% | $5.05 (−592.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers